NCT00365157: Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 168 taking part
- Started
- 23 Oct 2006
- Primary completion
- 9 Jul 2025
- Arms
- Treatment (eribulin mesylate)
- Results
- Posted on the registry
- 17 Aug 2006: Trial registered
- 23 Oct 2006: Trial started
- 9 Sep 2026: Trial results posted